dc.contributor.author | Güngör-Tuncer, Özlem | |
dc.contributor.author | Yılmaz, Vuslat | |
dc.contributor.author | Parman, Fatma Yeşim | |
dc.contributor.author | Deymeer, Feza | |
dc.contributor.author | Saruhan Direskeneli, Güher | |
dc.contributor.author | Tüzün, Erdem | |
dc.contributor.author | Durmuş Tekçe, Hacer | |
dc.contributor.author | Oflazer, Piraye | |
dc.contributor.author | Aysal, Ferit | |
dc.date.accessioned | 2021-03-02T17:05:01Z | |
dc.date.available | 2021-03-02T17:05:01Z | |
dc.identifier.citation | Yılmaz V., Tüzün E., Durmuş Tekçe H., Oflazer P., Aysal F., Parman F. Y. , Güngör-Tuncer Ö., Deymeer F., Saruhan Direskeneli G., "The treatment effect on peripheral B cell markers in antibody positive myasthenia gravis patients", Journal Of Neuroimmunology, cilt.349, ss.577402, 2020 | |
dc.identifier.issn | 0165-5728 | |
dc.identifier.other | av_45462018-387f-4388-a239-fae8cee154e2 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/3473 | |
dc.identifier.uri | https://www.sciencedirect.com/science/article/abs/pii/S0165572820302204 | |
dc.identifier.uri | https://doi.org/10.1016/j.jneuroim.2020.577402 | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.title | The treatment effect on peripheral B cell markers in antibody positive myasthenia gravis patients | |
dc.type | Makale | |
dc.relation.journal | Journal Of Neuroimmunology | |
dc.contributor.department | İstanbul Üniversitesi , Deneysel Tıp Araştırma Enstitüsü , Sinirbilim Ad | |
dc.identifier.volume | 349 | |
dc.identifier.startpage | 577402 | |
dc.identifier.endpage | 577402 | |
dc.contributor.firstauthorID | 2250578 | |